ANSWER: The prostate specific antigen (PSA) test is a way to screen for prostate cancer. It is not perfect, but when used properly, it can save lives by identifying men who have early prostate cancer ...

PSA blood test A study of 400,887 men in an integrated health system, the first to evaluate various PSA screening intervals and age groups, concluded that yearly screening is the interval of choice.

Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.

Current guidelines recommend against screening for prostate cancer in men who are 70 years old and older, as it is considered to be 'low value' with little or no benefit for the individual. Yet a new ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

NEW YORK (Reuters Health) - The possible benefits and harms of prostate cancer screening have been hotly debated in recent years, but for the first time a new study tries to put a number on the ...

As prostate cancer cases rise in India, routine PSA tests are leading to anxiety. Doctors emphasise that not every elevated ...

Researchers used 2018 data from the National Health Interview Survey to investigate the association. Men taking anxiety and depression medications were more likely to undergo prostate specific antigen ...

A prostate biopsy is a procedure to remove small samples of tissue from the prostate gland. It's a method to test for prostate cancer if a prostate-specific antigen (PSA) blood test or digital rectal ...

Using MRI scans in screening for prostate cancer could detect tumours missed by prostate-specific antigen (PSA) blood testing alone, according to a major new study from University College London (UCL) ...

Share on Pinterest Scientists are working on developing a urine test to detect prostate cancer. Anchalee Phanmaha/Getty Images Early detection of prostate cancer remains a major clinical challenge due ...